title: [Vincristine-induced recurrent laryngeal nerve paralysis].
authors.forename: E
authors.initials: E
authors.lastname: Núñez
authors.forename: D
authors.initials: D
authors.lastname: Solano
authors.forename: A
authors.initials: A
authors.lastname: Arreita
authors.forename: R
authors.initials: R
authors.lastname: Franco-Vicario
authors.forename: F
authors.initials: F
authors.lastname: Miguel
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012009:Recurrent Laryngeal Nerve / Q000187:drug effects*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*; D014826:Vocal Cord Paralysis / Q000139:chemically induced*
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Parálisis recurrencial inducida por vincristina.